THE FIRST AND ONLY FDA-APPROVED BIOSIMILAR INTERCHANGEABLE WITH LUCENTIS®
FOR ALL INDICATIONS1
Created to be similar,
With distinct value
Expect the same efficacy and safety as Lucentis® (ranibizumab injection) with the comprehensive support and savings of CIMERLI™
Expect the same efficacy and safety as Lucentis® (ranibizumab injection) with the comprehensive support and savings of CIMERLI™
CIMERLI™ has attributes identical to Lucentis®1:
- Same FDA-approved indications
- Same dosage strengths (0.3 mg & 0.5 mg)
- Same formulation & excipients
- Same amino acid sequence